Haoqiang Ying

20PUBLICATIONS
201CO-AUTHORS
Molecular targetsCancer diagnosisCancer cell biologyMetabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 11, 2026
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer.

|Jan 06, 2026
The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma.

Menna-T-Allah Shaheen, Sarah Dhebat, Kimal I Rajapakshe

|Dec 02, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Ziheng Chen, I-Lin Ho, Jintan Liu

|Sep 18, 2025
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer.

Yongkun Wei, Minghui Liu, Er-Yen Yen

|Oct 29, 2024
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer.

Yohei Saito, Yi Xiao, Jun Yao

|Oct 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series.

Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef

Pageof 4

Frequent Collaborators

7 joint publications

Anirban Maitra

7 joint publications

Huamin Wang

5 joint publications

Er-Yen Yen

5 joint publications

Wantong Yao